Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.
Share:
More In Business
Big Business This Week: Market Is A Big Fan of Turbines
DNA firm is back under old management, Meta is poaching AI talent, TikTok's deadline looms, Kraft goes natural with dyes, and WhatsApp introduces ads.
New Amazon factory aims to deliver 10,000 robotaxis annually
Amazon is gearing up to make as 10,000 robotaxis annually at a sprawling plant near Silicon Valley.
How the humble water gun became the symbol of Barcelona’s anti-tourism movement
The humble water gun — the cheap, squirt-squirt variety — has become the weapon of choice and symbol of Spain's anti-tourism protests.
Trump Family Crypto Empire: A Web of Millions, Influence, and Ethical Concerns
Sam Blum, Senior Writer at Inc. Magazine, discusses one of his latest articles on why the Trump family is embracing crypto. Watch!
Real Assets Gain Traction in Bank of America's 2025 Specialty Asset Management Outlook
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health Raises Pharmaceutical Segment Profit Guidance 12-13% for FY25
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
Leonard Lauder who globalized family cosmetic business, dies at 92
Leonard Lauder, a renowned philanthropist who expanded the family cosmetics business into a worldwide empire, has died at the age of 92.
Inside the CRE Market: Peachtree Group CEO Breaks Down Industry Trends
Peachtree CEO Greg Friedman on the hospitality business, commercial real estate and what the numbers are telling you. Watch!
Autonomous Ambitions: How Oshkosh is Steering Commercial Vehicles into the Future with AI
Oshkosh CEO John Pfeifer joins J.D. Durkin to discuss artificial intelligence, autonomy, and reinventing commercial vehicles. Watch!
